IDIOPATHIC INFLAMMATORY MYOPATHIES
Clinical trials for IDIOPATHIC INFLAMMATORY MYOPATHIES explained in plain language.
Never miss a new study
Get alerted when new IDIOPATHIC INFLAMMATORY MYOPATHIES trials appear
Sign up with your email to follow new studies for IDIOPATHIC INFLAMMATORY MYOPATHIES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental cell therapy targets Hard-to-Treat autoimmune diseases
Disease control TerminatedThis early-stage study is testing the safety and initial effects of a new cell therapy called RD06-04 for people with active, severe autoimmune diseases. The therapy involves modifying a patient's own immune cells (CAR-T cells) to target and remove certain harmful immune cells. T…
Matched conditions: IDIOPATHIC INFLAMMATORY MYOPATHIES
Phase: EARLY_PHASE1 • Sponsor: Nanjing Bioheng Biotech Co., Ltd. • Aim: Disease control
Last updated Apr 01, 2026 21:47 UTC
-
Scientists test 'Living Drug' to reboot immune system in devastating autoimmune conditions
Disease control ENROLLING_BY_INVITATIONThis is an early-stage study testing a new type of cell therapy called Prula-cel for adults with severe autoimmune diseases that haven't responded well to standard treatments. The therapy involves giving patients specially engineered immune cells designed to target and remove har…
Matched conditions: IDIOPATHIC INFLAMMATORY MYOPATHIES
Phase: PHASE1 • Sponsor: Adicet Therapeutics • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Experimental cell therapy aims to tame severe, untreatable autoimmune diseases
Disease control OngoingThis early-stage study is testing a new cell therapy called CNTY-101 in people with severe autoimmune diseases like lupus, lupus nephritis, and scleroderma that have not improved with other treatments. The main goals are to find a safe dose and see if the therapy helps control th…
Matched conditions: IDIOPATHIC INFLAMMATORY MYOPATHIES
Phase: PHASE1 • Sponsor: Century Therapeutics, Inc. • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
Scientists test 'Living Drug' to reset the immune system in devastating autoimmune conditions
Disease control OngoingThis early-stage study is testing the safety and initial effects of a personalized cell therapy called KYV-101 in adults with severe autoimmune diseases. The therapy involves collecting a patient's own immune cells, modifying them to target harmful B cells, and reinfusing them. U…
Matched conditions: IDIOPATHIC INFLAMMATORY MYOPATHIES
Phase: PHASE1 • Sponsor: David Porter • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC
-
Can a powerful shingles shot be safe for vulnerable patients?
Prevention OngoingThis study is checking if the Shingrix shingles vaccine is safe and works well for people with autoimmune rheumatic diseases like lupus or rheumatoid arthritis. These patients are at high risk for shingles but are often on medications that weaken the immune system. Researchers ar…
Matched conditions: IDIOPATHIC INFLAMMATORY MYOPATHIES
Phase: PHASE4 • Sponsor: University of Sao Paulo General Hospital • Aim: Prevention
Last updated Mar 25, 2026 14:08 UTC